Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Is IVL safe for patients with diabetes?
New two-year data confirm that the IVL technology developed by Shockwave Medical can be used to treat diabetic patients who require PCI.
FDA announces Class I recall of patches used for heart surgery
There is a risk of certain pericardial patches not being as strong or durable as needed. Customers are urged to identify, quarantine and replace these devices.
Catheters recalled due to defect—FDA highlights risk of stroke or brain damage
The recall was put in place after a hydrophilic coating was discovered on the inside of the devices. According to the FDA, patients treated with the catheters could face a number of significant risks.
IVC filter recalled due to injury risk
Customers are urged to stop using these devices right away.
FDA clears new-look robotic system from Stereotaxis
GenesisX represents the company’s most accessible robotic system to date. It requires no room shielding or structural anchoring, for example, and the size has been significantly reduced.

DOACs outperform VKAs among cardiac amyloidosis patients with HF, AFib

Outcomes from patients prescribed apixaban, rivaroxaban or dabigatran were compared with outcomes from patients given warfarin.

DAPT after PCI can stop after 1 month, new research confirms

The study, published in the Journal of the American College of Cardiology, examined outcomes from more than 3,000 patients.

Some hospitalized COVID-19 patients may need anticoagulation therapy at discharge

Researchers focused on rates of venous thromboembolism among COVID-19 patients at their own health system, sharing their work in JAMA Network Open.

Multicenter trial to evaluate IVL treatment for peripheral lesions below the knee

The Disrupt BTK II study will include 250 patients overall.

New study compares polymer and polymer-free drug-eluting stents after 3 years

The analysis included outcomes data from nearly 1,500 PCI patients.

Q&A: Cleveland Clinic cardiologist details the past, present and future of drug-eluting stents

Amar Krishnaswamy, MD, shared his thoughts on this important technology in an exclusive interview.

PAD specialists announce new FDA clearance for image-guided atherectomy system

The solution is now cleared as a treatment option for in-stent restenosis in the lower extremity arteries.

We may finally know why type 2 diabetes is associated with vascular damage

New research published in Diabetes provides some potential answers to a big question.

Vascular & Endovascular

Is IVL safe for patients with diabetes?

FDA announces Class I recall of patches used for heart surgery

Catheters recalled due to defect—FDA highlights risk of stroke or brain damage

IVC filter recalled due to injury risk

FDA clears new-look robotic system from Stereotaxis